Celyad Oncology

Celyad is a provider of cell therapy treatments with an initial focus on cardiology and oncology,

Total raised

€29M

€28,767,426

Funding rounds

Investors

distinct backers

Active since

2021-12

latest 2021-12

Funding by year

EUR raised per year

High confidence

Raise-next likelihood11

base rate 30% for Other

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

1 rounds

Date	Stage	Amount	Investors
2021-12-06	Other	€29M	Fortress Investment Group	View deal →

same sector or country